Financials
- Market Capitalization 974.21 M
- Employee 68
- Founded 2019
- CEO -
- Website www.altoneuroscience.com
- Headquarter Delaware, United States
- FIGI BBG00WYFS6R5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-9.25
ratio cours/chiffre d'affaires
-4 977.22
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2486 | LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.20 USD | +3.77% | -3.51% | +12.82% | +91.30% | 977.23 M USD | ||
| 2489 | AVTX Avalo Therapeutics, Inc. - Common Stock | 18.55 USD | +0.71% | -3.39% | +27.14% | +282.47% | 975.09 M USD | ||
| 2510 | SLDB Solid Biosciences Inc. - Common Stock | 9.62 USD | -0.10% | -12.31% | +31.78% | +68.77% | 947.09 M USD | ||
| 2516 | PHAR Pharming Group N.V. - ADS, each representing 10 | 13.31 USD | -0.82% | -5.47% | +4.31% | +33.23% | 933.94 M USD |